Home
Conditions
HER2-positive Breast Cancer

Clinical trial condition

HER2-positive Breast Cancer

Explore clinical trials studying HER2-positive Breast Cancer. Study availability and eligibility vary by location and protocol.

202 public trials 83 recruiting studies

Refine in advanced search Browse all conditions

HER2-positive Breast Cancer trial results

Not Yet Recruiting

RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With Prior TOP1i-ADC Failure

NCT07366840

Conditions: Breast Diseases, Breast Neoplasms, HER2-positive Breast Cancer, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Platform Trial Assessing Uptake, Safety and Efficacy of Theranostic Agents in Solid Tumors With Active Brain Metastases

NCT07178938

Conditions: HER2-positive Breast Cancer, Solid Tumors
Locations: Not specified

View Trial Details

Not Yet Recruiting

Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With Herombopag

NCT07198672

Conditions: HER2-positive Breast Cancer
Locations: Not specified

View Trial Details

Not Yet Recruiting

Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study

NCT07179939

Conditions: HER2-positive Breast Cancer
Locations: Fudan University Shanghai, China

View Trial Details

Not Yet Recruiting

T-DXd With or Without Neratinib for HER2 Positive Breast Cancer With Brain Metastasis

NCT07152782

Conditions: Breast Cancer With Brain Metastasis, HER2-positive Breast Cancer
Locations: Not specified

View Trial Details

Not Yet Recruiting

HB1801 Combined Treatment of HER2-positive Breast Cancer

NCT07116824

Conditions: HER2-positive Breast Cancer
Locations: Not specified

View Trial Details

Not Yet Recruiting

This Study Aims to Optimize Neoadjuvant Therapy for HER2-positive Breast Cancer by Implementing a Dynamic Monitoring-guided Treatment Strategy.

NCT06973525

Conditions: HER2-positive Breast Cancer
Locations: Not specified

View Trial Details

Not Yet Recruiting

Neratinib in Extended Adjuvant Treatment for HER2+ Early Breast Cancer With pCR But High-Risk Features: A Hebei Multi-Center Real-World Study

NCT07019272

Conditions: HER2-positive Breast Cancer
Locations: Not specified

View Trial Details

Not Yet Recruiting

Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer

NCT07019337

Conditions: Breast Diseases, Breast Neoplasms, HER2-positive Breast Cancer, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Pyrotinib in HER2-positive Early Breast Cancer

NCT06718335

Conditions: HER2-positive Breast Cancer
Locations: Not specified

View Trial Details

HER2-positive Breast Cancer

HER2-positive Breast Cancer trial results

Related conditions